Robert Muckle, MD
Otolaryngology · Englewood, CONPI 1245215284
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,250 of the $2,510 with a category attached, or 89.6%. Cochlear Americas accounts for 92.4% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $2,296 and has fallen 98.7% since, to $31 in 2025.
Across 13 payments — averaging $193.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cochlear Americas$2K
- Med-el Corporation$57
- Medtronic$50
- Advanced Bionics, LLC$40
- Novartis$17
- Biohaven Pharmaceutical Holding Company Ltd.$13
- plus $12 from 1 others
What the payments were for
- Consulting fees$2,25090%
- Food & beverage$26010%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cochlear Americas | 6 | $2,320 |
| Med-el Corporation | 1 | $57 |
| Medtronic | 1 | $50 |
| Advanced Bionics, LLC | 2 | $40 |
| Novartis | 1 | $17 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,510 in reported general payments places this provider in the 70th percentile of 174 otolaryngology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 183 | $1,655 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 14 | $1,468 |
| Spironolactone | 82 | $1,111 |
| Potassium Chloride | 26 | $629 |
| Ofloxacin | 22 | $555 |
| Furosemide | 45 | $242 |
| Prednisone | 37 | $239 |
| Verapamil ErVerapamil Hcl | 13 | $143 |
| Diazepam | 39 | $131 |
| Alprazolam | 23 | $127 |
| Hydrochlorothiazide | 16 | $106 |
| Methylprednisolone | 18 | $104 |
| Lorazepam | 15 | $97 |
| Sertraline Hcl | 16 | $38 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Englewood
- Suzanne BertramFort Collins$475K
- Barton KnoxColorado Springs$164K
- Nicholas BeckmannColorado Springs$151K
- Vijay RamakrishnanAurora$128K
- Michael WilhelmColorado Springs$76K
- Andrew WinklerAurora$68K
- David OppermanDenver$67K
- Robert KellerColorado Springs$45K
- Peter SchmidLongmont$45K
- Ashoke KhanwalkarAurora$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.